Identification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expression

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Josowitz, Rebecca ^a   Lu, Jia ^b   Falce, Christine ^a   D'Souza, Sunita L ^a   Wu, Meng ^a   Cohen, Ninette ^a   Dubois, Nicole C ^a   Zhao, Yong ^a   Sobie, Eric A ^a   Fishman, Glenn I ^b   Gelb, Bruce D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MUSCLE PROTEIN; PROTEOLIPID; SARCOLIPIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTROPORATION; FLOW CYTOMETRY; FLUORESCENCE; GENE; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN STEM CELL DERIVED ATRIAL LIKE CARDIOMYOCYTE; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MONITORING; PURIFICATION; SARCOLIPIN GENE; CYTOLOGY; GENETICS; HEART ATRIUM; METABOLISM; PLURIPOTENT STEM CELL; PROCEDURES; REPORTER GENE;

CALCIUM; CELL DIFFERENTIATION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; ELECTROPHYSIOLOGICAL PROCESSES; FLOW CYTOMETRY; GENE EXPRESSION; GENES, REPORTER; HEART ATRIA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUSCLE PROTEINS; MYOCYTES, CARDIAC; PROTEOLIPIDS;

EID: 84904255600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101316     Document Type: Article

References (31)

1. Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, et al. (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111: 344-358.
2. Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, et al. (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4: 130ra147.
3. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, et al. (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465: 808-812.
4. Caspi O, Itzhaki I, Kehat I, Gepstein A, Arbel G, et al. (2009) In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev 18: 161-172.
5. Mercola M, Colas A, Willems E (2013) Induced pluripotent stem cells in cardiovascular drug discovery. Circ Res 112: 534-548.
6. Small EM, Krieg PA (2004) Molecular regulation of cardiac chamber-specific gene expression. Trends Cardiovasc Med 14: 13-18. (Pubitemid 38068206)
7. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, et al. (2013) Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 77: 1307-1314.
8. Babu GJ, Bhupathy P, Carnes CA, Billman GE, Periasamy M (2007) Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J Mol Cell Cardiol 43: 215-222. (Pubitemid 47069382)
9. Minamisawa S, Wang Y, Chen J, Ishikawa Y, Chien KR, et al. (2003) Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem 278: 9570-9575. (Pubitemid 36800451)
10. Vangheluwe P, Schuermans M, Zador E, Waelkens E, Raeymaekers L, et al. (2005) Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem J 389: 151-159. (Pubitemid 40978018)
11. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33: e36.
12. Costa M, Dottori M, Sourris K, Jamshidi P, Hatzistavrou T, et al. (2007) A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc 2: 792-796. (Pubitemid 46745575)
13. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528. (Pubitemid 351733312)
14. Willems E, Spiering S, Davidovics H, Lanier M, Xia Z, et al. (2011) Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res 109: 360-364.
15. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, et al. (2011) SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 29: 1011-1018.
16. Kisselbach L, Merges M, Bossie A, Boyd A (2009) CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures. Cytotechnology 59: 31-44.
17. Walden AP, Dibb KM, Trafford AW (2009) Differences in intracellular calcium homeostasis between atrial and ventricular myocytes. J Mol Cell Cardiol 46: 463-473.
18. Bootman MD, Smyrnias I, Thul R, Coombes S, Roderick HL (2011) Atrial cardiomyocyte calcium signalling. Biochim Biophys Acta 1813: 922-934.
19. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, et al. (2003) Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285: H2355-2363. (Pubitemid 37443051)
20. Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, et al. (2011) High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 301: H2006-2017.
21. Varro A, Nanasi PP, Lathrop DA (1993) Potassium currents in isolated human atrial and ventricular cardiocytes. Acta Physiol Scand 149: 133-142. (Pubitemid 23313119)
22. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E (2004) Pharmacology of cardiac potassium channels. Cardiovasc Res 62: 9-33. (Pubitemid 38326808)
23. Li GR, Dong MQ (2010) Pharmacology of cardiac potassium channels. Adv Pharmacol 59: 93-134.
24. Kim C, Majdi M, Xia P, Wei KA, Talantova M, et al. (2010) Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 19: 783-795.
25. Yang X, Pabon L, Murry CE (2014) Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114: 511-523.
26. Hatem SN, Coulombe A, Balse E (2010) Specificities of atrial electrophysiology: Clues to a better understanding of cardiac function and the mechanisms of arrhythmias. J Mol Cell Cardiol 48: 90-95.
27. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, et al. (2009) Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460: 113-117.
28. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, et al. (2000) Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14: 2540-2548.
29. Hoogaars WM, Engel A, Brons JF, Verkerk AO, de Lange FJ, et al. (2007) Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev 21: 1098-1112. (Pubitemid 46686478)
30. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, et al. (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325.
31. Don CW, Murry CE (2013) Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med 17: 1355-1362.